QNCX   $1.9700000000000002  -5.29% Market Closed After Close 1.91 -3.05%

Quince Therapeutics Inc
Total Cash 59.45M
totalCashPerShare 1.374
EBITDA -29.13M
Total Debt 14.38M
quickRatio 5.853
currentRatio 6.146
Total Revenue
debtToEquity 30.619
Revenue/Share
ROA -0.16496
ROE -0.79376
grossProfits
freeCashflow -7.84M
operatingCashflow -27.99M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 18.12M
forwardPE -4.7096777
floatShares 34.60M
sharesOutstanding 43.28M
sharesShort 1.91M
sharesShortPriorMonth 1.96M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.25%
Short Ratio help_outline 30.08%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.085
Price To Book help_outline 1.35
earningsQuarterlyGrowth
netIncomeToCommon -53.12M
trailingEps -1.26%
forwardEps -0.31%
enterpriseToEbitda -0.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 4Q 2022
institutionsCount 54
lastUpdated Nov. 7, 2024, 3:10 p.m.